+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Structural Heart Occlusion Devices Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
Structural Heart Occlusion Devices Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
New

Structural Heart Occlusion Devices Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • PDF Icon

    Report

  • 196 Pages
  • May 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 6079386
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
In recent years, advancements in occlusion device design and delivery systems have fundamentally reshaped the treatment paradigm for structural heart defects. Minimally invasive approaches that once seemed experimental are now routine, offering patients reduced procedural risk, shorter hospital stays, and faster recoveries. As life expectancy increases and congenital heart disease is diagnosed earlier, the demand for reliable, precise occlusion solutions continues to rise.

These devices, engineered to seal abnormal cardiac openings and leaks, span a diverse range of applications-from atrial septal defect closures in adults to patent ductus arteriosus interventions in neonates. Innovative materials such as nitinol allow for self-expanding configurations that adapt to complex anatomies, while improvements in imaging and catheter technology enable unprecedented procedural accuracy. This introduction sets the stage for an in-depth exploration of the transformative forces, regulatory shifts, and market dynamics driving the next generation of structural heart occlusion therapies.

Transformative Shifts Reshaping the Structural Heart Landscape

Over the past decade, rapid technological innovation has redefined what is possible in structural heart care. High-resolution intracardiac imaging, combined with computer-aided device planning, allows clinicians to simulate occluder deployment before ever entering the catheterization lab. At the same time, material science breakthroughs-such as bioresorbable polymers and enhanced metal alloys-have led to devices that provide immediate mechanical support and then gradually integrate with surrounding tissue.

Regulatory environments have also adapted, streamlining approval pathways for breakthrough device classifications while reinforcing safety through post-market surveillance. This regulatory balance encourages manufacturers to innovate, accelerating clinical trials and expanding patient access.

Patient preferences and clinical protocols have shifted toward less invasive, outpatient procedures. Hybrid therapy models, which blend surgical and catheter-based techniques, are gaining traction in specialized centers. As a result, providers are investing in cross-disciplinary teams and infrastructure that support seamless transitions between interventional and surgical modalities, signaling a new era in personalized cardiac care.

Cumulative Impact of United States Tariffs in 2025

The introduction of new tariffs on key device components in the United States during 2025 has had a multifaceted impact on the structural heart occlusion market. Import duties on nitinol wire, stainless steel tubing, and specialized catheter assemblies have driven up production costs, compelling manufacturers to reassess sourcing strategies and negotiate long-term supply agreements to stabilize pricing.

In response, several leading firms have accelerated the localization of critical manufacturing processes, transferring heat-treatment and laser-cutting operations to domestic facilities. This strategic shift not only mitigates tariff exposure but also enhances supply chain resilience, reducing lead times and improving responsiveness to fluctuating clinical demand.

Payer negotiations have become more complex, as providers face pressure to contain procedural costs. Some device developers have implemented bundled pricing models and outcome-based agreements to secure favorable reimbursement. Meanwhile, emerging competitors in allied regions are capitalizing on cost advantages, intensifying the need for innovation and value demonstration in a tariff-influenced marketplace.

Key Segmentation Insights Driving Market Dynamics

A detailed segmentation analysis reveals distinct growth pockets and innovation drivers across multiple dimensions. When device type is considered, atrial septal defect occlusion devices maintain a lead due to broad adult indications, while left atrial appendage occlusion continues to expand among stroke-prevention protocols in non-valvular atrial fibrillation. Para-valvular leak closure solutions are emerging as a niche focus within structural heart interventions; devices for patent ductus arteriosus remain critical for neonatal care, and ventricular septal defect closures underpin complex congenital programs.

Examining end users, hospitals dominate procedural volume thanks to comprehensive care teams and hybrid operating suites, whereas ambulatory surgical centers are growing rapidly by offering streamlined percutaneous therapy packages. Specialty clinics, particularly those focused on interventional and pediatric cardiology, are carving out dedicated patient pathways for high-risk cases.

Material categorization highlights nitinol-based designs as the gold standard for self-expanding profiles, while stainless steel-based devices retain advantages in balloon-expandable configurations. Within clinical applications, adult cardiology accounts for the largest share, interventional cardiology continues to push technology frontiers, and pediatric cardiology demands bespoke miniaturized profiles.

Product structure segmentation underscores the strategic choice between balloon-expandable devices-favored for precise deployment-and self-expanding devices, prized for conformability in irregular anatomies. When therapy type is weighed, percutaneous options outpace surgical therapy, though hybrid therapy is poised for selective growth in complex cases.

Assessing occlusion mechanism, mechanical occlusion remains prevalent, but biodegradable occlusion is gaining traction as clinicians prioritize long-term vessel integrity. Technology platforms break down into balloon-based and plug-based devices, with the latter further differentiated into cylindrical plug designs for tubular defects and disk-shaped plugs optimized for septal closures.

Age group analysis reveals strong demand among adults and geriatric patients, while neonates and pediatric segments drive innovation in miniaturization and biocompatibility. Finally, risk category stratification shows moderate-risk procedures forming the backbone of volume, with high-risk and low-risk segments each presenting targeted R&D and clinical training opportunities.

Geographic Trends Highlighting Regional Variations

Regional dynamics reflect a complex interplay of healthcare infrastructure, reimbursement frameworks, and demographic trends. In the Americas, robust payer support and established interventional networks sustain high adoption rates of advanced occlusion therapies, especially within centers of excellence that collaborate on clinical research. Meanwhile, Europe, the Middle East & Africa are characterized by gradual reimbursement harmonization, where early-adopter countries lead in minimally invasive adoption and peripheral markets watch for cost-effectiveness data before scaling deployment.

Asia-Pacific is arguably the most dynamic region, driven by rising healthcare expenditures, expanding hospital capacity, and strategic technology partnerships. Local device manufacturers are leveraging domestic clinical trials to accelerate approvals, while established global players form joint ventures to navigate complex regulatory landscapes. Across all regions, tele-training programs and remote proctoring are enhancing procedural standardization, ensuring that best practices diffuse swiftly across geographic boundaries.

Competitive Landscape Featuring Key Industry Players

Market leadership is shaped by a blend of legacy product portfolios and forward-looking innovation pipelines. Abbott Laboratories continues to set benchmarks with its broad occlusion portfolio, while B. Braun Melsungen AG invests heavily in biodegradable occluder research. Biotronik, Inc. is expanding its structural heart franchise through targeted acquisitions and cutting-edge nitinol processing techniques. Boston Scientific Corporation leverages cross-business synergies to accelerate hybrid therapy solutions, and Edwards Lifesciences Corporation builds on its hemodynamics expertise to introduce advanced plug-based closures.

Emerging players are equally influential: JenaValve Technology, Inc. is exploring transcatheter leak closure adjuncts; Keystone Heart Ltd. forms strategic alliances to penetrate underserved markets; Lifetech Scientific Corporation taps into regional scale in Asia; Medtronic plc extends its platform reach across congenital and adult interventional segments; MicroPort Scientific Corporation focuses on cost-efficient manufacturing; Occlutech International AB pioneers novel disk geometries; St. Jude Medical LLC integrates synergies post-merger; Transcatheter Technologies GmbH customizes solutions for complex anatomies; and W. L. Gore & Associates, Inc. refines ePTFE coatings for enhanced biocompatibility.

Actionable Recommendations for Industry Leadership

Reinforce R&D investment in bioresorbable materials and smart self-expanding architectures to meet evolving clinical demands. Diversify manufacturing footprints by establishing regional hubs that mitigate tariff exposure and compress delivery timelines. Elevate value-based contracting with payers by leveraging real-world evidence to demonstrate cost savings and patient outcomes.

Adopt integrated imaging and AI-driven guidance platforms, enabling precision deployment and reducing procedural variability. Forge partnerships with academic centers and specialty clinics to accelerate clinical validation and drive early adoption. Prioritize pediatric and high-risk segment solutions through tailored device miniaturization and dedicated clinician training programs.

Engage regulators proactively by participating in advisory panels and standard-setting consortia, ensuring that emerging therapies align with safety benchmarks and approval pathways. Expand presence in Asia-Pacific through local joint ventures, co-development agreements, and region-specific clinical studies. Implement a comprehensive risk-management framework that addresses supply chain volatility, regulatory shifts, and competitive pressures.

Conclusion Emphasizing Strategic Imperatives

The structural heart occlusion landscape stands at a pivotal junction where innovation, regulation, and economics converge. Proven segmentation insights reveal targeted growth opportunities, while tariff-driven supply chain adjustments underscore the importance of operational agility. Regional analysis highlights diverse adoption curves, and the competitive tableau showcases both established giants and nimble challengers racing to define the next generation of occlusion therapies.

Success will favor those who blend technological leadership with strategic market access, deploying capital efficiently against the most promising segments and geographies. By embracing data-driven decision-making, fostering collaborative ecosystems, and prioritizing patient-centric design, device developers and healthcare providers can unlock new avenues of growth and elevate standards of care.

Market Segmentation & Coverage

This research report categorizes the Structural Heart Occlusion Devices Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Atrial Septal Defect Occlusion Devices
  • Left Atrial Appendage Occlusion Devices
  • Para-Valvular Leak Closure Devices
  • Patent Ductus Arteriosus Occlusion Devices
  • Ventricular Septal Defect Occlusion Devices
  • Ambulatory Surgical Centers
  • Hospitals
  • Specialty Clinics
  • Nitinol-Based Devices
  • Stainless Steel-Based Devices
  • Adult Cardiology
  • Interventional Cardiology
  • Pediatric Cardiology
  • Balloon-Expandable Devices
  • Self-Expanding Devices
  • Hybrid Therapy
  • Percutaneous Therapy
  • Surgical Therapy
  • Biodegradable Occlusion
  • Mechanical Occlusion
  • Balloon-Based Devices
  • Plug-Based Devices
    • Cylindrical Plugs
    • Disk Shaped Plugs
  • Adults
  • Geriatric
  • Neonates
  • Pediatric
  • High Risk
  • Low Risk
  • Moderate Risk

This research report categorizes the Structural Heart Occlusion Devices Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Structural Heart Occlusion Devices Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Biotronik, Inc.
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • JenaValve Technology, Inc.
  • Keystone Heart Ltd.
  • Lifetech Scientific Corporation
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Occlutech International AB
  • St. Jude Medical LLC (a subsidiary of Abbott)
  • Transcatheter Technologies GmbH
  • W. L. Gore & Associates, Inc.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Structural Heart Occlusion Devices Market, by Device Type
8.1. Introduction
8.2. Atrial Septal Defect Occlusion Devices
8.3. Left Atrial Appendage Occlusion Devices
8.4. Para-Valvular Leak Closure Devices
8.5. Patent Ductus Arteriosus Occlusion Devices
8.6. Ventricular Septal Defect Occlusion Devices
9. Structural Heart Occlusion Devices Market, by End User
9.1. Introduction
9.2. Ambulatory Surgical Centers
9.3. Hospitals
9.4. Specialty Clinics
10. Structural Heart Occlusion Devices Market, by Material
10.1. Introduction
10.2. Nitinol-Based Devices
10.3. Stainless Steel-Based Devices
11. Structural Heart Occlusion Devices Market, by Applications
11.1. Introduction
11.2. Adult Cardiology
11.3. Interventional Cardiology
11.4. Pediatric Cardiology
12. Structural Heart Occlusion Devices Market, by Product Structure
12.1. Introduction
12.2. Balloon-Expandable Devices
12.3. Self-Expanding Devices
13. Structural Heart Occlusion Devices Market, by Therapy Type
13.1. Introduction
13.2. Hybrid Therapy
13.3. Percutaneous Therapy
13.4. Surgical Therapy
14. Structural Heart Occlusion Devices Market, by Occlusion Mechanism
14.1. Introduction
14.2. Biodegradable Occlusion
14.3. Mechanical Occlusion
15. Structural Heart Occlusion Devices Market, by Technology Used
15.1. Introduction
15.2. Balloon-Based Devices
15.3. Plug-Based Devices
15.3.1. Cylindrical Plugs
15.3.2. Disk Shaped Plugs
16. Structural Heart Occlusion Devices Market, by Age Group
16.1. Introduction
16.2. Adults
16.3. Geriatric
16.4. Neonates
16.5. Pediatric
17. Structural Heart Occlusion Devices Market, by Risk Category
17.1. Introduction
17.2. High Risk
17.3. Low Risk
17.4. Moderate Risk
18. Americas Structural Heart Occlusion Devices Market
18.1. Introduction
18.2. Argentina
18.3. Brazil
18.4. Canada
18.5. Mexico
18.6. United States
19. Asia-Pacific Structural Heart Occlusion Devices Market
19.1. Introduction
19.2. Australia
19.3. China
19.4. India
19.5. Indonesia
19.6. Japan
19.7. Malaysia
19.8. Philippines
19.9. Singapore
19.10. South Korea
19.11. Taiwan
19.12. Thailand
19.13. Vietnam
20. Europe, Middle East & Africa Structural Heart Occlusion Devices Market
20.1. Introduction
20.2. Denmark
20.3. Egypt
20.4. Finland
20.5. France
20.6. Germany
20.7. Israel
20.8. Italy
20.9. Netherlands
20.10. Nigeria
20.11. Norway
20.12. Poland
20.13. Qatar
20.14. Russia
20.15. Saudi Arabia
20.16. South Africa
20.17. Spain
20.18. Sweden
20.19. Switzerland
20.20. Turkey
20.21. United Arab Emirates
20.22. United Kingdom
21. Competitive Landscape
21.1. Market Share Analysis, 2024
21.2. FPNV Positioning Matrix, 2024
21.3. Competitive Analysis
21.3.1. Abbott Laboratories
21.3.2. B. Braun Melsungen AG
21.3.3. Biotronik, Inc.
21.3.4. Boston Scientific Corporation
21.3.5. Edwards Lifesciences Corporation
21.3.6. JenaValve Technology, Inc.
21.3.7. Keystone Heart Ltd.
21.3.8. Lifetech Scientific Corporation
21.3.9. Medtronic plc
21.3.10. MicroPort Scientific Corporation
21.3.11. Occlutech International AB
21.3.12. St. Jude Medical LLC (a subsidiary of Abbott)
21.3.13. Transcatheter Technologies GmbH
21.3.14. W. L. Gore & Associates, Inc.
22. ResearchAI
23. ResearchStatistics
24. ResearchContacts
25. ResearchArticles
26. Appendix
List of Figures
FIGURE 1. STRUCTURAL HEART OCCLUSION DEVICES MARKET MULTI-CURRENCY
FIGURE 2. STRUCTURAL HEART OCCLUSION DEVICES MARKET MULTI-LANGUAGE
FIGURE 3. STRUCTURAL HEART OCCLUSION DEVICES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY MATERIAL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY APPLICATIONS, 2024 VS 2030 (%)
FIGURE 14. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY APPLICATIONS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PRODUCT STRUCTURE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PRODUCT STRUCTURE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY THERAPY TYPE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY THERAPY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY OCCLUSION MECHANISM, 2024 VS 2030 (%)
FIGURE 20. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY OCCLUSION MECHANISM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY TECHNOLOGY USED, 2024 VS 2030 (%)
FIGURE 22. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY TECHNOLOGY USED, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 24. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY RISK CATEGORY, 2024 VS 2030 (%)
FIGURE 26. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY RISK CATEGORY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. AMERICAS STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. AMERICAS STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. UNITED STATES STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 30. UNITED STATES STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 31. ASIA-PACIFIC STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 32. ASIA-PACIFIC STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 33. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 34. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 35. STRUCTURAL HEART OCCLUSION DEVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 36. STRUCTURAL HEART OCCLUSION DEVICES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. STRUCTURAL HEART OCCLUSION DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY ATRIAL SEPTAL DEFECT OCCLUSION DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY LEFT ATRIAL APPENDAGE OCCLUSION DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PARA-VALVULAR LEAK CLOSURE DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PATENT DUCTUS ARTERIOSUS OCCLUSION DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY VENTRICULAR SEPTAL DEFECT OCCLUSION DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY NITINOL-BASED DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY STAINLESS STEEL-BASED DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY ADULT CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY INTERVENTIONAL CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PEDIATRIC CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PRODUCT STRUCTURE, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY BALLOON-EXPANDABLE DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY SELF-EXPANDING DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY HYBRID THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PERCUTANEOUS THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY SURGICAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY OCCLUSION MECHANISM, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY BIODEGRADABLE OCCLUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY MECHANICAL OCCLUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY BALLOON-BASED DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PLUG-BASED DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY CYLINDRICAL PLUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY DISK SHAPED PLUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PLUG-BASED DEVICES, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY NEONATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY RISK CATEGORY, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY HIGH RISK, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY LOW RISK, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY MODERATE RISK, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PRODUCT STRUCTURE, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY OCCLUSION MECHANISM, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PLUG-BASED DEVICES, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY RISK CATEGORY, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PRODUCT STRUCTURE, 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 66. ARGENTINA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY OCCLUSION MECHANISM, 2018-2030 (USD MILLION)
TABLE 67. ARGENTINA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 68. ARGENTINA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PLUG-BASED DEVICES, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY RISK CATEGORY, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PRODUCT STRUCTURE, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY OCCLUSION MECHANISM, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PLUG-BASED DEVICES, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY RISK CATEGORY, 2018-2030 (USD MILLION)
TABLE 82. CANADA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 83. CANADA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. CANADA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 85. CANADA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 86. CANADA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PRODUCT STRUCTURE, 2018-2030 (USD MILLION)
TABLE 87. CANADA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 88. CANADA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY OCCLUSION MECHANISM, 2018-2030 (USD MILLION)
TABLE 89. CANADA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 90. CANADA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PLUG-BASED DEVICES, 2018-2030 (USD MILLION)
TABLE 91. CANADA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 92. CANADA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY RISK CATEGORY, 2018-2030 (USD MILLION)
TABLE 93. MEXICO STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 94. MEXICO STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. MEXICO STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 96. MEXICO STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 97. MEXICO STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PRODUCT STRUCTURE, 2018-2030 (USD MILLION)
TABLE 98. MEXICO STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 99. MEXICO STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY OCCLUSION MECHANISM, 2018-2030 (USD MILLION)
TABLE 100. MEXICO STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 101. MEXICO STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PLUG-BASED DEVICES, 2018-2030 (USD MILLION)
TABLE 102. MEXICO STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 103. MEXICO STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY RISK CATEGORY, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 107. UNITED STATES STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 108. UNITED STATES STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PRODUCT STRUCTURE, 2018-2030 (USD MILLION)
TABLE 109. UNITED STATES STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 110. UNITED STATES STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY OCCLUSION MECHANISM, 2018-2030 (USD MILLION)
TABLE 111. UNITED STATES STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 112. UNITED STATES STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PLUG-BASED DEVICES, 2018-2030 (USD MILLION)
TABLE 113. UNITED STATES STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 114. UNITED STATES STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY RISK CATEGORY, 2018-2030 (USD MILLION)
TABLE 115. UNITED STATES STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 116. ASIA-PACIFIC STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 117. ASIA-PACIFIC STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. ASIA-PACIFIC STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 119. ASIA-PACIFIC STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 120. ASIA-PACIFIC STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PRODUCT STRUCTURE, 2018-2030 (USD MILLION)
TABLE 121. ASIA-PACIFIC STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 122. ASIA-PACIFIC STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY OCCLUSION MECHANISM, 2018-2030 (USD MILLION)
TABLE 123. ASIA-PACIFIC STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 124. ASIA-PACIFIC STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PLUG-BASED DEVICES, 2018-2030 (USD MILLION)
TABLE 125. ASIA-PACIFIC STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 126. ASIA-PACIFIC STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY RISK CATEGORY, 2018-2030 (USD MILLION)
TABLE 127. ASIA-PACIFIC STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 128. AUSTRALIA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 129. AUSTRALIA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. AUSTRALIA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 131. AUSTRALIA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 132. AUSTRALIA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PRODUCT STRUCTURE, 2018-2030 (USD MILLION)
TABLE 133. AUSTRALIA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 134. AUSTRALIA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY OCCLUSION MECHANISM, 2018-2030 (USD MILLION)
TABLE 135. AUSTRALIA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 136. AUSTRALIA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PLUG-BASED DEVICES, 2018-2030 (USD MILLION)
TABLE 137. AUSTRALIA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 138. AUSTRALIA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY RISK CATEGORY, 2018-2030 (USD MILLION)
TABLE 139. CHINA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 140. CHINA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 141. CHINA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 142. CHINA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 143. CHINA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PRODUCT STRUCTURE, 2018-2030 (USD MILLION)
TABLE 144. CHINA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 145. CHINA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY OCCLUSION MECHANISM, 2018-2030 (USD MILLION)
TABLE 146. CHINA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 147. CHINA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PLUG-BASED DEVICES, 2018-2030 (USD MILLION)
TABLE 148. CHINA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 149. CHINA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY RISK CATEGORY, 2018-2030 (USD MILLION)
TABLE 150. INDIA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 151. INDIA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 152. INDIA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 153. INDIA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 154. INDIA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PRODUCT STRUCTURE, 2018-2030 (USD MILLION)
TABLE 155. INDIA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 156. INDIA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY OCCLUSION MECHANISM, 2018-2030 (USD MILLION)
TABLE 157. INDIA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 158. INDIA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PLUG-BASED DEVICES, 2018-2030 (USD MILLION)
TABLE 159. INDIA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 160. INDIA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY RISK CATEGORY, 2018-2030 (USD MILLION)
TABLE 161. INDONESIA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 162. INDONESIA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 163. INDONESIA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 164. INDONESIA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 165. INDONESIA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PRODUCT STRUCTURE, 2018-2030 (USD MILLION)
TABLE 166. INDONESIA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 167. INDONESIA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY OCCLUSION MECHANISM, 2018-2030 (USD MILLION)
TABLE 168. INDONESIA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 169. INDONESIA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PLUG-BASED DEVICES, 2018-2030 (USD MILLION)
TABLE 170. INDONESIA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 171. INDONESIA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY RISK CATEGORY, 2018-2030 (USD MILLION)
TABLE 172. JAPAN STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 173. JAPAN STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. JAPAN STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 175. JAPAN STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 176. JAPAN STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PRODUCT STRUCTURE, 2018-2030 (USD MILLION)
TABLE 177. JAPAN STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 178. JAPAN STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY OCCLUSION MECHANISM, 2018-2030 (USD MILLION)
TABLE 179. JAPAN STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 180. JAPAN STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PLUG-BASED DEVICES, 2018-2030 (USD MILLION)
TABLE 181. JAPAN STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 182. JAPAN STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY RISK CATEGORY, 2018-2030 (USD MILLION)
TABLE 183. MALAYSIA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 184. MALAYSIA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. MALAYSIA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 186. MALAYSIA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 187. MALAYSIA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PRODUCT STRUCTURE, 2018-2030 (USD MILLION)
TABLE 188. MALAYSIA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 189. MALAYSIA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY OCCLUSION MECHANISM, 2018-2030 (USD MILLION)
TABLE 190. MALAYSIA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 191. MALAYSIA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PLUG-BASED DEVICES, 2018-2030 (USD MILLION)
TABLE 192. MALAYSIA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 193. MALAYSIA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY RISK CATEGORY, 2018-2030 (USD MILLION)
TABLE 194. PHILIPPINES STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 195. PHILIPPINES STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 196. PHILIPPINES STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 197. PHILIPPINES STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 198. PHILIPPINES STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PRODUCT STRUCTURE, 2018-2030 (USD MILLION)
TABLE 199. PHILIPPINES STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 200. PHILIPPINES STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY OCCLUSION MECHANISM, 2018-2030 (USD MILLION)
TABLE 201. PHILIPPINES STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 202. PHILIPPINES STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PLUG-BASED DEVICES, 2018-2030 (USD MILLION)
TABLE 203. PHILIPPINES STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 204. PHILIPPINES STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY RISK CATEGORY, 2018-2030 (USD MILLION)
TABLE 205. SINGAPORE STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 206. SINGAPORE STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. SINGAPORE STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 208. SINGAPORE STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 209. SINGAPORE STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PRODUCT STRUCTURE, 2018-2030 (USD MILLION)
TABLE 210. SINGAPORE STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 211. SINGAPORE STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY OCCLUSION MECHANISM, 2018-2030 (USD MILLION)
TABLE 212. SINGAPORE STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 213. SINGAPORE STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PLUG-BASED DEVICES, 2018-2030 (USD MILLION)
TABLE 214. SINGAPORE STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 215. SINGAPORE STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY RISK CATEGORY, 2018-2030 (USD MILLION)
TABLE 216. SOUTH KOREA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 217. SOUTH KOREA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 218. SOUTH KOREA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 219. SOUTH KOREA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 220. SOUTH KOREA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PRODUCT STRUCTURE, 2018-2030 (USD MILLION)
TABLE 221. SOUTH KOREA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 222. SOUTH KOREA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY OCCLUSION MECHANISM, 2018-2030 (USD MILLION)
TABLE 223. SOUTH KOREA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 224. SOUTH KOREA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PLUG-BASED DEVICES, 2018-2030 (USD MILLION)
TABLE 225. SOUTH KOREA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 226. SOUTH KOREA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY RISK CATEGORY, 2018-2030 (USD MILLION)
TABLE 227. TAIWAN STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 228. TAIWAN STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. TAIWAN STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 230. TAIWAN STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 231. TAIWAN STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PRODUCT STRUCTURE, 2018-2030 (USD MILLION)
TABLE 232. TAIWAN STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 233. TAIWAN STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY OCCLUSION MECHANISM, 2018-2030 (USD MILLION)
TABLE 234. TAIWAN STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 235. TAIWAN STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PLUG-BASED DEVICES, 2018-2030 (USD MILLION)
TABLE 236. TAIWAN STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 237. TAIWAN STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY RISK CATEGORY, 2018-2030 (USD MILLION)
TABLE 238. THAILAND STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 239. THAILAND STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 240. THAILAND STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 241. THAILAND STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 242. THAILAND STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PRODUCT STRUCTURE, 2018-2030 (USD MILLION)
TABLE 243. THAILAND STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 244. THAILAND STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY OCCLUSION MECHANISM, 2018-2030 (USD MILLION)
TABLE 245. THAILAND STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 246. THAILAND STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PLUG-BASED DEVICES, 2018-2030 (USD MILLION)
TABLE 247. THAILAND STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 248. THAILAND STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY RISK CATEGORY, 2018-2030 (USD MILLION)
TABLE 249. VIETNAM STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 250. VIETNAM STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 251. VIETNAM STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 252. VIETNAM STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 253. VIETNAM STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PRODUCT STRUCTURE, 2018-2030 (USD MILLION)
TABLE 254. VIETNAM STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 255. VIETNAM STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY OCCLUSION MECHANISM, 2018-2030 (USD MILLION)
TABLE 256. VIETNAM STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 257. VIETNAM STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PLUG-BASED DEVICES, 2018-2030 (USD MILLION)
TABLE 258. VIETNAM STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 259. VIETNAM STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY RISK CATEGORY, 2018-2030 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PRODUCT STRUCTURE, 2018-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY OCCLUSION MECHANISM, 2018-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PLUG-BASED DEVICES, 2018-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY RISK CATEGORY, 2018-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 272. DENMARK STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 273. DENMARK STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 274. DENMARK STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 275. DENMARK STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 276. DENMARK STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PRODUCT STRUCTURE, 2018-2030 (USD MILLION)
TABLE 277. DENMARK STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 278. DENMARK STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY OCCLUSION MECHANISM, 2018-2030 (USD MILLION)
TABLE 279. DENMARK STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 280. DENMARK STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PLUG-BASED DEVICES, 2018-2030 (USD MILLION)
TABLE 281. DENMARK STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 282. DENMARK STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY RISK CATEGORY, 2018-2030 (USD MILLION)
TABLE 283. EGYPT STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 284. EGYPT STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 285. EGYPT STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 286. EGYPT STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 287. EGYPT STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PRODUCT STRUCTURE, 2018-2030 (USD MILLION)
TABLE 288. EGYPT STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 289. EGYPT STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY OCCLUSION MECHANISM, 2018-2030 (USD MILLION)
TABLE 290. EGYPT STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 291. EGYPT STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY PLUG-BASED DEVICES, 2018-2030 (USD MILLION)
TABLE 292. EGYPT STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 293. EGYPT STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY RISK CATEGORY, 2018-2030 (USD MILLION)
TABLE 294. FINLAND STRUCTURAL HEART OCCLUSION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TA

Companies Mentioned

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Biotronik, Inc.
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • JenaValve Technology, Inc.
  • Keystone Heart Ltd.
  • Lifetech Scientific Corporation
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Occlutech International AB
  • St. Jude Medical LLC (a subsidiary of Abbott)
  • Transcatheter Technologies GmbH
  • W. L. Gore & Associates, Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

United States Interventional Cardiology Market Outlook to 2033 - Coronary Stents, PTCA Balloon Catheters, Transcatheter Accessories and Others - Product Image

United States Interventional Cardiology Market Outlook to 2033 - Coronary Stents, PTCA Balloon Catheters, Transcatheter Accessories and Others

  • Report
  • 17 Pages
  • United States
From
North America Interventional Cardiology Market Outlook to 2033 - Coronary Stents, PTCA Balloon Catheters, Transcatheter Accessories and Others - Product Image

North America Interventional Cardiology Market Outlook to 2033 - Coronary Stents, PTCA Balloon Catheters, Transcatheter Accessories and Others

  • Report
  • 174 Pages
  • North America
From
Transcatheter Devices Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030 - Product Image

Transcatheter Devices Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • Report
  • 194 Pages
  • Global
From
Occlusion Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Occlusion Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Transcatheter Embolization And Occlusion Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Transcatheter Embolization And Occlusion Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.